Aduro Biotech announced the establishment of a major collaboration with Novartis Read the full story

Arrowhead Research announced the acquisition of Novartis' entire RNAi research and development portfolio and associated assets Read the full story

India-based CLARIS Lifesciences Ltd., which operates a generic sterile injectables business, has become the belle of the ball as multi-national companies such as Pfizer Inc., Amneal, Novartis AG and Indian companies such as Lupin and Cipla, are lining up to play the Read the full story

Novartis , the world's biggest pharmaceutical (big pharma) company, recently increased its interest in Israel to sign pharma deals. For a long time, the company was active in marketing and clinical trials in Israel, and now it is involved in investment as well. Read the full story

Aspen has entered into an agreement with Novartis in terms of which it will acquire the rights to Mono-Embolex Read the full story

Novartis Pharmaceuticals announced the establishment of a joint investment company with Qualcomm Ventures to target early stage companies Read the full story

BioLineRx has entered into a multi-year strategic collaboration agreement with Novartis Pharma designed to facilitate development and commercialization of Israeli-sourced drug candidates Read the full story

Novartis announced has entered an agreement that CSL has acquired its influenza vaccine business in a $275 million deal that will require regulatory approval before it closes by the end of the second half of 2015. Read the full story